Systemic markers of inflammation are associated with cardiac allograft vasculopathy and an increased intimal inflammatory component

American Journal of Transplantation

Volumn 10, Issue 6, 2010, Pages 1428-1436

  Arora, S ^a,b   Gunther, A ^c   Wennerblom, B ^d   Ueland, T ^a   Andreassen, A K ^a   Gude, E ^a   Endresen, K ^a   Geiran, O ^b,c   Wilhelmsen, N ^c   Andersen, R ^c   Aukrust, P ^a,c   Gullestad, L ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Inflammatory mediators; Intravascular ultrasound; Transplant arteriosclerosis

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; NEOPTERIN; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC DISEASE; ALLOTRANSPLANTATION; BLOOD; CHEMISTRY; HEART LUNG TRANSPLANTATION; INTIMA; METABOLISM; MIDDLE AGED;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA; VASCULAR CELL ADHESION MOLECULE-1; VON WILLEBRAND FACTOR;

EID: 77953000267     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03118.x     Document Type: Article

References (36)

1. Taylor DO, Edwards LB, Boucek MM et al. Registry of the international society for heart and lung transplantation: Twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 2006 25 : 869 879.
2. Raichlin ER, McConnell JP, Lerman A et al. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant 2007 26 : 826 833.
3. Arora S, Gullestad L, Wergeland R et al. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Transplantation 2007 83 : 1308 1315.
4. Faulk WP, Rose M, Meroni PL et al. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 1999 60 : 826 832.
5. Valantine H, Pinto FJ, St Goar FG, Alderman EL, Popp RL. Intracoronary ultrasound imaging in heart transplant recipients: The Stanford experience. J Heart Lung Transplant 1992 11 (3 Pt 2 S60 S64.
6. Nasu K, Tsuchikane E, Katoh O et al. Accuracy of in vivo coronary plaque morphology assessment: A validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 2006 20 47 : 2405 2412.
7. Nair A, Margolis M, Kuban B, Vince DG. Automated coronary plaque characterisation with intravascular ultrasound backscatter: Ex vivo validation. EuroIntervention 2007 3 : 113 120.
8. Mintz GS, Nissen SE, Anderson WD et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001 37 : 1478 1492.
9. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002 106 : 2200 2206.
10. Raichlin E, Bae JH, Kushwaha SS et al. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol 2009 53 : 1279 1286.
11. Nasu K, Tsuchikane E, Katoh O et al. Plaque characterisation by virtual histology intravascular ultrasound analysis in patients with type 2 diabetes. Heart 2008 94 : 429 433.
12. Rodriguez-Granillo GA, Garcia-Garcia HM, Mc Fadden EP et al. In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis. J Am Coll Cardiol 2005 46 : 2038 2042.
13. Hong YJ, Jeong MH, Choi YH et al. Plaque characteristics in culprit lesions and inflammatory status in diabetic acute coronary syndrome patients. JACC Cardiovasc Imaging 2009 2 : 339 349.
14. Funada R, Oikawa Y, Yajima J et al. The potential of RF backscattered IVUS data and multidetector-row computed tomography images for tissue characterization of human coronary atherosclerotic plaques. Int J Cardiovasc Imaging 2009 25 : 471 478.
15. Bollerslev J, Ueland T, Jorgensen AP et al. Positive effects of a physiological dose of GH on markers of atherogenesis: A placebo-controlled study in patients with adult-onset GH deficiency. Eur J Endocrinol 2006 154 : 537 543.
16. Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 : 361 387.
17. Steyerberg EW, Harrell FE, Jr. et al. Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001 54 : 774 781.
18. Arora S, Jenum PA, Aukrust P et al. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality. J Am Coll Cardiol 2007 50 : 1967 1972.
19. Pethig K, Heublein B, Kutschka I, Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy: High-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation 2000 102 (19 Suppl 3 III233 III236.
20. Hognestad A, Endresen K, Wergeland R et al. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 2003 42 : 477 482.
21. Valantine HA. Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant "atheroma". Transplantation 2003 76 : 891 899.
22. Konig A, Klauss V. Virtual histology. Heart 2007 93 : 977 982.
23. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 2006 47 (8 Suppl C19 C31.
24. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005 294 : 326 333.
25. Aukrust P, Halvorsen B, Yndestad A et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008 28 : 1909 1919.
26. Russell ME, Wallace AF, Hancock WW et al. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 1995 59 : 572 578.
27. Alpers CE, Davis CL, Barr D, Marsh CL, Hudkins KL. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 1996 148 : 439 451.
28. Hayry P, Myllarniemi M, Aavik E et al. Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J 1995 9 : 1336 1344.
29. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 2003 52 : 313 321.
30. Ardehali A, Laks H, Drinkwater DC, Ziv E, Drake TA. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Circulation 1995 92 : 450 456.
31. McManus BM, Horley KJ, Wilson JE et al. Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol 1995 147 : 293 308.
32. Mitchell RN. Graft vascular disease: Immune response meets the vessel wall. Annu Rev Pathol 2009 4 : 19 47.
33. Tsutsui H, Ziada KM, Schoenhagen P et al. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: Results from a 5-year serial intravascular ultrasound study. Circulation 2001 104 : 653 657.
34. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 1989 8 : 349 359.
35. Valantine HA. Cardiac allograft vasculopathy: Central role of endothelial injury leading to transplant "atheroma". Transplantation 2003 76 : 891 899.
36. Day JD, Rayburn BK, Gaudin PB et al. Cardiac allograft vasculopathy: The central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant 1995 14 (6 Pt 2 S142 S149.